Psychotropic medications associated with pediatric ADRs in Denmark: Researchers

Between 1998 and 2007, psychotropic medications were associated with 429 adverse drug reactions (ADRs) in children under 17 in Denmark. Researchers writing in the open access journal BMC Research Notes found that more than half of these were serious and several were birth defects - suggesting that tighter controls on the prescription of psychotropic medications to pregnant women may be required.

Lise Aagaard and Ebba Holme Hansen from the University of Copenhagen, Denmark, studied all 4500 pediatric adverse drug reaction reports submitted during the study period to find those which were linked to psychotropic medications. Aagaard said, "The high number of serious ADRs reported for psychotropic medicines in the paediatric population should be a concern for health care professionals and physicians".

The two researchers found that the largest share of adverse reactions (42%) was reported for psychostimulants (such as Ritalin), followed by 31% for antidepressants (such as Prozac) and 24% for antipsychotics (such as Haldol) . A number of ADRs were reported for Danish children below 2 years, probably due to the mother's intake of psychotropic medicine, primarily antidepressants and antipsychotics, during pregnancy. Serious ADRs such as 'neonatal withdrawal syndrome', 'ventricular septal defects' and 'premature labour' were reported. According to Aagaard, "Considering the higher number of birth defects being reported greater care has to be taken while prescribing these drugs for pregnant women."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Children's Colorado earns prestigious cardiomyopathy recognition